SC Linn

430 total citations
30 papers, 283 citations indexed

About

SC Linn is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, SC Linn has authored 30 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 14 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in SC Linn's work include Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (7 papers) and BRCA gene mutations in cancer (5 papers). SC Linn is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (7 papers) and BRCA gene mutations in cancer (5 papers). SC Linn collaborates with scholars based in Netherlands, United States and Belgium. SC Linn's co-authors include Hilde Rosing, Jos A. van der Hage, Liesbeth Boersma, Luc J. A. Strobbe, A. Helen Westenberg, Lori M. van Roozendaal, Marjolein L. Smidt, Thijs van Dalen, Marc B. I. Lobbes and Philip Poortmans and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

SC Linn

30 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
SC Linn Netherlands	8	168	138	96	68	46	30	283
Szabolcs Ottó Hungary	11	99 0.6×	209 1.5×	162 1.7×	47 0.7×	60 1.3×	24	375
Adher Alsayed Saudi Arabia	10	111 0.7×	173 1.3×	35 0.4×	33 0.5×	33 0.7×	19	304
Ning‐Fu Peng China	12	131 0.8×	150 1.1×	30 0.3×	65 1.0×	71 1.5×	20	356
Nat Pernick United States	7	122 0.7×	101 0.7×	129 1.3×	106 1.6×	34 0.7×	11	316
So Young Kang South Korea	7	182 1.1×	129 0.9×	69 0.7×	86 1.3×	33 0.7×	13	349
Cristina Aguayo Spain	7	72 0.4×	167 1.2×	99 1.0×	65 1.0×	85 1.8×	17	301
Teresa Staiano Italy	11	66 0.4×	118 0.9×	29 0.3×	82 1.2×	72 1.6×	19	289
Silvia Ruscelli Italy	8	79 0.5×	244 1.8×	50 0.5×	50 0.7×	67 1.5×	15	304
Deirdre Kelly Canada	10	107 0.6×	165 1.2×	35 0.4×	52 0.8×	83 1.8×	30	362
In Ae Park South Korea	9	146 0.9×	208 1.5×	45 0.5×	33 0.5×	90 2.0×	11	337

Countries citing papers authored by SC Linn

Since Specialization

Citations

This map shows the geographic impact of SC Linn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SC Linn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SC Linn more than expected).

Fields of papers citing papers by SC Linn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SC Linn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SC Linn. The network helps show where SC Linn may publish in the future.

Co-authorship network of co-authors of SC Linn

This figure shows the co-authorship network connecting the top 25 collaborators of SC Linn. A scholar is included among the top collaborators of SC Linn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SC Linn. SC Linn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jóźwiak, Katarzyna, et al.. (2024). Cox proportional hazards regression in small studies of predictive biomarkers. Scientific Reports. 14(1). 14232–14232. 2 indexed citations

Boersma, Liesbeth, Lori M. van Roozendaal, Sander M. J. van Kuijk, et al.. (2023). Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial. Radiotherapy and Oncology. 191. 110069–110069. 7 indexed citations

Korse, Catharina M., SC Linn, Hilde Rosing, et al.. (2020). A real or apparent decrease in glomerular filtration rate in patients using olaparib?. European Journal of Clinical Pharmacology. 77(2). 179–188. 26 indexed citations

Tovey, Holly, Jelmar Quist, Syed Mahmood Haider, et al.. (2019). Abstract P1-06-07: Characterization of chromosomal instability in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012). Cancer Research. 79(4_Supplement). P1–6. 1 indexed citations

Vliek, S.B., Agnes Jager, Anthony Gonçalvès, et al.. (2018). Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial. Cancer Research. 78(4_Supplement). OT2–7. 2 indexed citations

Kok, Marleen, Hugo M. Horlings, T. Wiersma, et al.. (2017). Adaptive phase II randomized non-comparative trial of nivolumab after induction treatment in triple negative breast cancer: TONIC-trial. Annals of Oncology. 28. v608–v608. 21 indexed citations

Steenbruggen, Tessa G., Astrid N. Scholten, Ingrid A.M. Mandjes, et al.. (2017). Selecting patients with oligo-metastatic breast cancer harboring homologous recombination deficiency (HRD) for intensified chemotherapy: The OLIGO-study. Annals of Oncology. 28. v104–v104. 1 indexed citations

Roozendaal, Lori M. van, Thijs van Dalen, Jos A. van der Hage, et al.. (2017). Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08). BMC Cancer. 17(1). 459–459. 101 indexed citations

Kranenbarg, Elma Meershoek‐Klein, Hein Putter, Yvonne van Riet, et al.. (2017). Abstract S6-02: The efficacy and safety of the addition of ibandronate to adjuvant hormonal therapy in postmenopausal women with hormone-receptor positive early breast cancer. First results of the TEAM IIB trial (BOOG 2006-04). Cancer Research. 77(4_Supplement). S6–2. 2 indexed citations

10.

Rodenhuis, Sjoerd, et al.. (2017). Abstract P4-21-30: Long-term survival in HER2-positive metastatic breast cancer: The first blow is half the battle. Cancer Research. 77(4_Supplement). P4–21. 1 indexed citations

11.

Nekljudova, Valentina, Carsten Denkert, G von Minckwitz, et al.. (2016). Abstract P3-07-28: BRCA1-like profile as predictive biomarker in non myeloablative chemotherapy (GAIN study). Cancer Research. 76(4_Supplement). P3–7. 1 indexed citations

12.

Linn, SC, et al.. (2016). Abstract PD5-02: The effect of trastuzumab-based therapy on overall survival in small, node-negative HER2-positive breast cancer: To treat or not to treat?. Cancer Research. 76(4_Supplement). PD5–2. 2 indexed citations

13.

Jager, Nynke G L, Hilde Rosing, Jan H.M. Schellens, J. H. Beijnen, & SC Linn. (2014). Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen. Breast Cancer Research and Treatment. 146(1). 137–144. 28 indexed citations

14.

Dalen, T van, et al.. (2012). Abstract OT2-1-03: The Z11 design for breast cancer patients undergoing a mastectomy. Cancer Research. 72(24_Supplement). OT2–1. 1 indexed citations

15.

Opdam, Mark, et al.. (2012). Abstract PD01-03: Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment. Cancer Research. 72(24_Supplement). PD01–3. 1 indexed citations

16.

Dalen, T van, et al.. (2012). Abstract OT2-1-02: Clinical node negative breast cancer patients undergoing breast conserving therapy: follow-up versus sentinel lymph node biopsy. Cancer Research. 72(24_Supplement). OT2–1. 8 indexed citations

17.

Jager, Agnes, SC Linn, H. de Graaf, et al.. (2011). PD07-07: Combination of Paclitaxel and Bevacizumab without or with Capecitabine as First-Line Treatment of HER2−Negative Locally Recurrent or Metastatic Breast Cancer (LR/MBC): First Results from a Randomized, Multicenter, Open-Label, Phase II Study of the Dutch Breast Cancer Trialists' Group (BOOG).. Cancer Research. 71(24_Supplement). PD07–7. 4 indexed citations

18.

Schilder, C., et al.. (2008). [The effect of hormone therapy on cognitive function in patients with breast cancer].. PubMed. 152(9). 494–8. 1 indexed citations

19.

Linn, SC, A.A.M. Hart, C. van Krimpen, et al.. (2006). A new independent validation of the 70-gene signature in node-negative breast cancer. European Journal of Cancer Supplements. 4(2). 131–131. 3 indexed citations

20.

Linn, SC, Giuseppe Giaccone, C.K. van Kalken, et al.. (1994). Complete remission of colorectal cancer: a pitfall in a multidrug resistance reversal trial. The Lancet. 343. 1648–1649. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact